Loading clinical trials...

Evaluation and Treatment of Patients With Connective Tissue Disease | Clinical Trials | Clareo Health

COMPLETEDNCT00076830

Evaluation and Treatment of Patients With Connective Tissue Disease

This study offers evaluation and treatment of patients with a suspected connective tissue disorder. The protocol is not designed to test new treatments; rather, patients receive standard care. The stu...

Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Evaluation of Children With Endocrine and Metabolic-Related Conditions

NCT02769975 · Adrenal Insufficiency, Growth Disorder, and more

RECRUITINGPhase 3

Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta

NCT07366086 · Osteogenesis Imperfecta

RECRUITINGPhase 2

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

NCT07062588 · Osteogenesis Imperfecta (OI)

RECRUITINGNA

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

NCT07412782 · Osteogenesis Imperfecta, Osteoporosis, and more

RECRUITINGPhase 4

Effects of Bisphosphonates on OI-Related Hearing Loss

NCT04152551 · Osteogenesis Imperfecta

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 24, 2026Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment180

Start dateMay 2004

Last updatedApr 24, 2026

Condition

Connective Tissue Disorders Osteogenesis Imperfecta Bone Diseases, Metabolic Melorheostosis

Locations shown

National Institutes of Health Clinical Center

Bethesda, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 24, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions